CCGTX | TRRDX | CCGTX / TRRDX | |
Total Expense Ratio | 1.42 | 0.60 | 237% |
Annual Report Gross Expense Ratio | 1.42 | 0.60 | 237% |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 15.053 | 13.477 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 50.2B | 26.4B | 190% |
Annual Yield % from dividends | 0.50 | 1.38 | 36% |
Returns for 1 year | 13.30 | 12.50 | 106% |
Returns for 3 years | 43.40 | 37.69 | 115% |
Returns for 5 years | 40.33 | 31.34 | 129% |
Returns for 10 years | 86.29 | 63.29 | 136% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 28.00 | 0.16 | +0.59% |
First Trust Nasdaq Pharmaceuticals ETF | |||
IDVO | 37.07 | 0.12 | +0.32% |
Amplify CWP International Enh Div IncETF | |||
NLR | 127.36 | 0.32 | +0.25% |
VanEck Uranium & Nuclear ETF | |||
LST | 39.27 | 0.09 | +0.23% |
Leuthold Select Industries ETF | |||
FAAR | 30.07 | -0.35 | -1.13% |
First Trust Alt Abs Ret Strat ETF |